Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
SIMCERE PHARMA: 2024 INTERIM REPORT
Sep 27 04:32 ET
SIMCERE PHARMA: ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2024
Aug 21 10:38 ET
SIMCERE PHARMA: DATE OF BOARD MEETING
Aug 9 04:49 ET
SIMCERE PHARMA: RESULTS ESTIMATE
Jul 30 09:15 ET
Read more
Updated: Nov 14, 2024
Strong Buy
Buy
Hold
Underperform
Sell
No Data